Susquehanna International Group, LLP Adaptimmune Therapeutics PLC Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$0.83 - $1.47 $9,711 - $17,199	11,700 New	11,700 $11,000
Q2 2021 Aug 11, 2021	SELL	$3.86 - $5.78 $243,566 - $364,718	-63,100 Reduced 69.34%	27,900 $119,000
Q1 2021 May 17, 2021	SELL	$4.9 - $6.83 $188,160 - $262,272	-38,400 Reduced 29.68%	91,000 $483,000
Q4 2020 Feb 16, 2021	SELL	$4.0 - $9.2 $396,000 - $910,799	-99,000 Reduced 43.35%	129,400 $697,000
Q3 2020 Nov 16, 2020	SELL	$7.66 - $10.78 $52,088 - $73,304	-6,800 Reduced 2.89%	228,400 $1.82 Million
Q2 2020 Aug 14, 2020	BUY	$2.58 - $12.1 $606,816 - $2.85 Million	235,200 New	235,200 $2.35 Million
Q4 2018 Feb 14, 2019	SELL	$3.76 - $14.16 $373,368 - $1.41 Million	-99,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$8.27 - $13.56 $354,783 - $581,724	42,900 Added 76.06%	99,300 $1.35 Million
Q2 2018 Aug 14, 2018	BUY	$10.42 - $13.74 $52,100 - $68,700	5,000 Added 9.73%	56,400 $669,000
Q1 2018 May 15, 2018	BUY	$7.1 - $11.56 $196,670 - $320,212	27,700 Added 116.88%	51,400 $577,000
Q4 2017 Feb 14, 2018	BUY	$6.68 - $8.74 $88,844 - $116,242	13,300 Added 127.88%	23,700 $158,000
Q3 2017 Nov 14, 2017	BUY	$4.93 - $8.93 $51,272 - $92,872	10,400	10,400 $85,000

152M

78.5K

36.5K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $160M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.